Tech Company Financing Transactions

Protai Funding Round

Grove Ventures, Pitango Venture Capital and private investors participated in a $8 million Seed venture round for Protai. The round was announced by the company on 1/8/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4 Boáz Ramat Gan
Tel Aviv, 5320047
Israel

Phone

Undisclosed

Website

www.protai.bio

Email Address

[email protected]

Overview

We are an AI-powered drug discovery startup that is revolutionizing the way new drugs can be discovered. We combine deep proteomics with machine learning to better combat complex diseases and create a healthier world.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eran Seger

        

Chief Technical Officer

Kirill Pevzner

        

Browse more venture capital transactions:

Prev: 1/8/2022: CryptoSlam venture capital transaction
Next: 1/8/2022: Pendulum venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary